Surveillance of in vivo resistance of Plasmodium falciparum to antimalarial drugs from 1992 to 1999 in Malabo (Equatorial Guinea)

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 5, 2003, Pages 598-601

  Roche, Jesús ^a   Guerra Neira, Ana ^b   Raso, José ^b   Benito, Agustín ^c  

^a Red de Investigación de Centros de Enfermedades Tropicales RICET Madrid   (Spain)

^b Hospital Regional de Malabo   (Equatorial Guinea)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; ELOQUINE; FANSIDAR; MEFLOQUINE; QUININE; PYRIMETHAMINE; SULFADOXINE;

AGE; ARTICLE; CHILD; DOSE RESPONSE; DRUG EFFICACY; EQUATORIAL GUINEA; FOLLOW UP; HEALTH SURVEY; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITOLOGY; PEDIATRIC HOSPITAL; PLASMODIUM FALCIPARUM; SINGLE DRUG DOSE; TREATMENT FAILURE; ANIMAL; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; INFANT; PRESCHOOL CHILD;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; EQUATORIAL GUINEA; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; QUININE; SULFADOXINE;

EID: 0038808687     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.598     Document Type: Article

References (17)

1. Villadary I, Paquet C, Hemelsdael E, Blanchard G, Saki ZM, 1997. In vivo drug sensitivity of P. falciparum in the Tabou region of Ivory Coast. Bull Soc Pathol Exot 90: 10-13.
2. Basco LK, Ringwald P, 1999. Molecular epidemiology of malaria in Younde, Cameroon. IV. Evolution of pyrimethamine resistance between 1994 and 1998. Am J Trop Med Hyg 61: 802-806.
3. Falade CO, Salako LA, Sowinmi A, Odoula AM, Larcier P, 1997. Comparative efficacy of halofantrine, chloroquine and sulfadoxine/pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg 91: 58-62.
4. Parola P, Ali I, Djermakoye F, Crassard N, Bendavid C, Faugere B, Condomines P, 1999. Chloroquine sensitivity of Plasmodium falciparum at the Gamkalley Clinic and the Nigerian armed forces PMI (Niamey, Niger). Bull Soc Pathol Exot 92: 317-319.
5. Wolday D, Kibreab T, Bukenya D, Hodes R, 1995. Sensitivity of P. falciparum in vivo to chloroquine and sulfadoxine/pyrimethamine in Rwandan patients in a refugee camp in Zaire. Trans R Soc Trop Med Hyg 89: 654-656.
6. Guiguemde TR, Aouba A, Ouedraogo JB, Lamizana L, 1994. Ten-year surveillance of drug resistant malaria in Burkina Faso (1982-1991). Am J Trop Med Hyg 50: 699-704.
7. Roche J, Ayecaba S, Amela C, Alvar J, Benito A, 1996. Epidemiological characteristics of malaria in Equatorial Guinea. Res Rev Parasitol 56: 99-104.
8. WHO, 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96.1077.
9. WHO, 1986. Chemotherapy of malaria. Bruce-Chawatt LJ, ed. Geneva: WHO.
10. Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK, 1998. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 7: 543-552.
11. Ekvall H, Premji Z, Bjorkman A, 1998. Chloroquine treatment for uncomplicated childhood malaria in an area with drug resistance: early treatment failure aggravates anemia. Trans R Soc Trop Med Hyg 92: 556-560.
12. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
13. Trigg JK, Mbwana H, Chambo O, Hills E, Watkins W, Curtis CF, 1997. Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in northeast Tanzania and a test of chlorproguanil/dapsone. Acta Tropica 63: 185-189.
14. Ogutu RB, Smoak BL, Nduati RW, Mbori-Ngacha DA, Mwathe F, Shanks GD, 2000. The efficacy of pyrimethamine/sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Trans R Soc Trop Med Hyg 94: 83-84.
15. WHO, 2001. Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation. 4-5 April 2001. Geneva: WHO.
16. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W, 2001. Chlorproguanil/dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358: 1218-1223.
17. WHO, 2001. The Use of Antimalarial Drugs: Report of a WHO Informal Consultation. 13-17 November 2001. Geneva: WHO.